Published by Benjamin Chiou on 10th October 2024
(Sharecast News) - GSK's $2.2bn payment to settle 93% of outstanding Zantac lawsuits in the US was close to the "best case scenario", according to Jefferies, which said the announcement should remove a significant weight on the share price.
URL: http://www.digitallook.com/dl/news/story/34615430/...